A citation-based method for searching scientific literature

Natalia Zamorano Cuervo, Audray Fortin, Elise Caron, Stéfany Chartier, Nathalie Grandvaux. Sci Signal 2021
Times Cited: 2







List of co-cited articles
1 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Design of amidobenzimidazole STING receptor agonists with systemic activity.
Joshi M Ramanjulu, G Scott Pesiridis, Jingsong Yang, Nestor Concha, Robert Singhaus, Shu-Yun Zhang, Jean-Luc Tran, Patrick Moore, Stephanie Lehmann, H Christian Eberl,[...]. Nature 2018
264
100

CD47 blockade augmentation of trastuzumab antitumor efficacy dependent on antibody-dependent cellular phagocytosis.
Li-Chung Tsao, Erika J Crosby, Timothy N Trotter, Pankaj Agarwal, Bin-Jin Hwang, Chaitanya Acharya, Casey W Shuptrine, Tao Wang, Junping Wei, Xiao Yang,[...]. JCI Insight 2019
50
50

Interferon-Gamma at the Crossroads of Tumor Immune Surveillance or Evasion.
Flávia Castro, Ana Patrícia Cardoso, Raquel Madeira Gonçalves, Karine Serre, Maria José Oliveira. Front Immunol 2018
461
50


Immunomic, genomic and transcriptomic characterization of CT26 colorectal carcinoma.
John C Castle, Martin Loewer, Sebastian Boegel, Jos de Graaf, Christian Bender, Arbel D Tadmor, Valesca Boisguerin, Thomas Bukur, Patrick Sorn, Claudia Paret,[...]. BMC Genomics 2014
192
50

Anti-PD-1 and Anti-CTLA-4 Therapies in Cancer: Mechanisms of Action, Efficacy, and Limitations.
Judith A Seidel, Atsushi Otsuka, Kenji Kabashima. Front Oncol 2018
536
50


STING ligand c-di-GMP improves cancer vaccination against metastatic breast cancer.
Dinesh Chandra, Wilber Quispe-Tintaya, Arthee Jahangir, Denise Asafu-Adjei, Ilyssa Ramos, Herman O Sintim, Jie Zhou, Yoshihiro Hayakawa, David K R Karaolis, Claudia Gravekamp. Cancer Immunol Res 2014
142
50

MAVS forms functional prion-like aggregates to activate and propagate antiviral innate immune response.
Fajian Hou, Lijun Sun, Hui Zheng, Brian Skaug, Qiu-Xing Jiang, Zhijian J Chen. Cell 2011
807
50

Prion-like Aggregation of Mitochondrial Antiviral Signaling Protein in Lupus Patients Is Associated With Increased Levels of Type I Interferon.
Wen-Hai Shao, Daniel H Shu, Yuxuan Zhen, Brendan Hilliard, Stephen O Priest, Matteo Cesaroni, Jenny P-Y Ting, Philip L Cohen. Arthritis Rheumatol 2016
35
50

Targeting the innate immunoreceptor RIG-I overcomes melanoma-intrinsic resistance to T cell immunotherapy.
Lina Such, Fang Zhao, Derek Liu, Beatrice Thier, Vu Thuy Khanh Le-Trilling, Antje Sucker, Christoph Coch, Natalia Pieper, Sebastian Howe, Hilal Bhat,[...]. J Clin Invest 2020
18
50

RIG-I-based immunotherapy enhances survival in preclinical AML models and sensitizes AML cells to checkpoint blockade.
Michael Ruzicka, Lars M Koenig, Simone Formisano, Daniel F R Boehmer, Binje Vick, Eva-M Heuer, Hanna Meinl, Lorenz Kocheise, Marcus Zeitlhöfler, Julia Ahlfeld,[...]. Leukemia 2020
16
50

Reactive oxygen species induce virus-independent MAVS oligomerization in systemic lupus erythematosus.
Iwona A Buskiewicz, Theresa Montgomery, Elizabeth C Yasewicz, Sally A Huber, Michael P Murphy, Richard C Hartley, Ryan Kelly, Mary K Crow, Andras Perl, Ralph C Budd,[...]. Sci Signal 2016
84
50

Vaccine-Induced Memory CD8+ T Cells Provide Clinical Benefit in HER2 Expressing Breast Cancer: A Mouse to Human Translational Study.
Erika J Crosby, William Gwin, Kimberly Blackwell, Paul K Marcom, Serena Chang, Holden T Maecker, Gloria Broadwater, Terry Hyslop, Sungjin Kim, Andre Rogatko,[...]. Clin Cancer Res 2019
24
50

Fundamental Mechanisms of Immune Checkpoint Blockade Therapy.
Spencer C Wei, Colm R Duffy, James P Allison. Cancer Discov 2018
50

Interferon-β signal may up-regulate PD-L1 expression through IRF9-dependent and independent pathways in lung cancer cells.
Yoshie Morimoto, Tsunao Kishida, Shin-Ichiro Kotani, Koichi Takayama, Osam Mazda. Biochem Biophys Res Commun 2018
34
50

Tumor Interferon Signaling Regulates a Multigenic Resistance Program to Immune Checkpoint Blockade.
Joseph L Benci, Bihui Xu, Yu Qiu, Tony J Wu, Hannah Dada, Christina Twyman-Saint Victor, Lisa Cucolo, David S M Lee, Kristen E Pauken, Alexander C Huang,[...]. Cell 2016
553
50


Interferons in the treatment of human cancer.
J M Kirkwood, M S Ernstoff. J Clin Oncol 1984
327
50

Immune checkpoint inhibitors for the treatment of MSI-H/MMR-D colorectal cancer and a perspective on resistance mechanisms.
Ibrahim Halil Sahin, Mehmet Akce, Olatunji Alese, Walid Shaib, Gregory B Lesinski, Bassel El-Rayes, Christina Wu. Br J Cancer 2019
118
50

Tumour and host cell PD-L1 is required to mediate suppression of anti-tumour immunity in mice.
Janet Lau, Jeanne Cheung, Armando Navarro, Steve Lianoglou, Benjamin Haley, Klara Totpal, Laura Sanders, Hartmut Koeppen, Patrick Caplazi, Jacqueline McBride,[...]. Nat Commun 2017
205
50

Crosstalk between Cytoplasmic RIG-I and STING Sensing Pathways.
Alessandra Zevini, David Olagnier, John Hiscott. Trends Immunol 2017
171
50

Gene therapy for head and neck cancer using vaccinia virus expressing IL-2 in a murine model, with evidence of immune suppression.
H Qin, J Valentino, S Manna, P K Tripathi, M Bhattacharya-Chatterjee, K A Foon, B W O'Malley, S K Chatterjee. Mol Ther 2001
33
50

STING contributes to antiglioma immunity via triggering type I IFN signals in the tumor microenvironment.
Takayuki Ohkuri, Arundhati Ghosh, Akemi Kosaka, Jianzhong Zhu, Maki Ikeura, Michael David, Simon C Watkins, Saumendra N Sarkar, Hideho Okada. Cancer Immunol Res 2014
140
50


Ligand-independent toll-like receptor signals generated by ectopic overexpression of MyD88 generate local and systemic antitumor immunity.
Zachary C Hartman, Takuya Osada, Oliver Glass, Xiao Y Yang, Gang-Jun Lei, H Kim Lyerly, Timothy M Clay. Cancer Res 2010
35
50

DNA-Demethylating Agents Target Colorectal Cancer Cells by Inducing Viral Mimicry by Endogenous Transcripts.
David Roulois, Helen Loo Yau, Rajat Singhania, Yadong Wang, Arnavaz Danesh, Shu Yi Shen, Han Han, Gangning Liang, Peter A Jones, Trevor J Pugh,[...]. Cell 2015
712
50

Mutations in DNA repair genes are associated with increased neoantigen burden and a distinct immunophenotype in lung squamous cell carcinoma.
Young Kwang Chae, Jonathan F Anker, Michael S Oh, Preeti Bais, Sandeep Namburi, Sarita Agte, Francis J Giles, Jeffrey H Chuang. Sci Rep 2019
43
50

Cutting edge: STING mediates protection against colorectal tumorigenesis by governing the magnitude of intestinal inflammation.
Qifan Zhu, Si Ming Man, Prajwal Gurung, Zhiping Liu, Peter Vogel, Mohamed Lamkanfi, Thirumala-Devi Kanneganti. J Immunol 2014
95
50

PD-L1 on tumor cells is sufficient for immune evasion in immunogenic tumors and inhibits CD8 T cell cytotoxicity.
Vikram R Juneja, Kathleen A McGuire, Robert T Manguso, Martin W LaFleur, Natalie Collins, W Nicholas Haining, Gordon J Freeman, Arlene H Sharpe. J Exp Med 2017
405
50

Host expression of PD-L1 determines efficacy of PD-L1 pathway blockade-mediated tumor regression.
Heng Lin, Shuang Wei, Elaine M Hurt, Michael D Green, Lili Zhao, Linda Vatan, Wojciech Szeliga, Ronald Herbst, Paul W Harms, Leslie A Fecher,[...]. J Clin Invest 2018
61
50

Suppression of STING signaling through epigenetic silencing and missense mutation impedes DNA damage mediated cytokine production.
Hiroyasu Konno, Shota Yamauchi, Anders Berglund, Ryan M Putney, James J Mulé, Glen N Barber. Oncogene 2018
92
50

Innate immune sensing and signaling of cytosolic nucleic acids.
Jiaxi Wu, Zhijian J Chen. Annu Rev Immunol 2014
692
50

Host type I IFN signals are required for antitumor CD8+ T cell responses through CD8{alpha}+ dendritic cells.
Mercedes B Fuertes, Aalok K Kacha, Justin Kline, Seng-Ryong Woo, David M Kranz, Kenneth M Murphy, Thomas F Gajewski. J Exp Med 2011
725
50


Innate immune recognition of cancer.
Seng-Ryong Woo, Leticia Corrales, Thomas F Gajewski. Annu Rev Immunol 2015
302
50

Growth of triple-negative breast cancer cells relies upon coordinate autocrine expression of the proinflammatory cytokines IL-6 and IL-8.
Zachary C Hartman, Graham M Poage, Petra den Hollander, Anna Tsimelzon, Jamal Hill, Nattapon Panupinthu, Yun Zhang, Abhijit Mazumdar, Susan G Hilsenbeck, Gordon B Mills,[...]. Cancer Res 2013
288
50

TRAIL and Noxa are selectively upregulated in prostate cancer cells downstream of the RIG-I/MAVS signaling pathway by nonreplicating Sendai virus particles.
Taeko Matsushima-Miyagi, Koji Hatano, Motonari Nomura, Liu Li-Wen, Tomoyuki Nishikawa, Kotaro Saga, Takashi Shimbo, Yasufumi Kaneda. Clin Cancer Res 2012
64
50

Histological and molecular evaluation of patient-derived colorectal cancer explants.
Joshua M Uronis, Takuya Osada, Shannon McCall, Xiao Yi Yang, Christopher Mantyh, Michael A Morse, H Kim Lyerly, Bryan M Clary, David S Hsu. PLoS One 2012
38
50

Targeted activation of innate immunity for therapeutic induction of autophagy and apoptosis in melanoma cells.
Damià Tormo, Agnieszka Checińska, Direna Alonso-Curbelo, Eva Pérez-Guijarro, Estela Cañón, Erica Riveiro-Falkenbach, Tonantzin G Calvo, Lionel Larribere, Diego Megías, Francisca Mulero,[...]. Cancer Cell 2009
137
50

Cancer immunotherapy using checkpoint blockade.
Antoni Ribas, Jedd D Wolchok. Science 2018
50

RIG-I-like receptors: their regulation and roles in RNA sensing.
Jan Rehwinkel, Michaela U Gack. Nat Rev Immunol 2020
348
50

Impact of oncogenic pathways on evasion of antitumour immune responses.
Stefani Spranger, Thomas F Gajewski. Nat Rev Cancer 2018
327
50


DNA repair defects and implications for immunotherapy.
Katherine M Bever, Dung T Le. J Clin Invest 2018
43
50

A subset of patients with MSS/MSI-low-colorectal cancer showed increased CD8(+) TILs together with up-regulated IFN-γ.
Tomohiro Kikuchi, Kosaku Mimura, Hirokazu Okayama, Yuko Nakayama, Katsuharu Saito, Leo Yamada, Eisei Endo, Wataru Sakamoto, Shotaro Fujita, Hisahito Endo,[...]. Oncol Lett 2019
29
50

The Clinical Impact of the Genomic Landscape of Mismatch Repair-Deficient Cancers.
Giovanni Germano, Nabil Amirouchene-Angelozzi, Giuseppe Rospo, Alberto Bardelli. Cancer Discov 2018
50
50

Pancreatic cancer-specific cell death induced in vivo by cytoplasmic-delivered polyinosine-polycytidylic acid.
Praveen Bhoopathi, Bridget A Quinn, Qin Gui, Xue-Ning Shen, Steven R Grossman, Swadesh K Das, Devanand Sarkar, Paul B Fisher, Luni Emdad. Cancer Res 2014
28
50

Endogenous retroviral proteins provide an immunodominant but not requisite antigen in a murine immunotherapy tumor model.
Xuan Ye, Janelle C Waite, Ankur Dhanik, Namita Gupta, Maggie Zhong, Christina Adler, Evangelia Malahias, Min Ni, Yi Wei, Cagan Gurer,[...]. Oncoimmunology 2020
8
50



Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.